Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Herzig

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Progress in Clinical and Biological Research|January 1, 1992
Bone marrow purging in patients with refractory cancerR C Meagher, D A Stevens, G P Herzig, et al.
Blood|November 11, 1975
Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentratesR H Herzig, G P Herzig, M I Bull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
Medical and Pediatric Oncology|January 1, 1982
Bone marrow transplantation with high-dose cytosine arabinosideR H Herzig, H M Lazarus, J Graham-Pole, et al.
Blood|April 1, 1988
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remissionP F Coccia, S E Strandjord, P I Warkentin, et al.
Lancet (London, England)|March 24, 1984
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemiaB Speck, M M Bortin, R Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancerH M Lazarus, R H Herzig, J Graham-Pole, et al.
Blood|October 1, 1993
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phaseJ M Goldman, R Szydlo, M M Horowitz, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Progress in Clinical and Biological Research|January 1, 1992
Bone marrow purging in patients with refractory cancerR C Meagher, D A Stevens, G P Herzig, et al.
Blood|November 11, 1975
Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentratesR H Herzig, G P Herzig, M I Bull, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
High-dose thiotepa with autologous bone marrow transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplantation GroupS N Wolff, R H Herzig, J W Fay, et al.
Seminars in Oncology|June 1, 1987
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an updateS N Wolff, R H Herzig, G L Phillips, et al.
Medical and Pediatric Oncology|January 1, 1982
Bone marrow transplantation with high-dose cytosine arabinosideR H Herzig, H M Lazarus, J Graham-Pole, et al.
Blood|April 1, 1988
High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remissionP F Coccia, S E Strandjord, P I Warkentin, et al.
Lancet (London, England)|March 24, 1984
Allogeneic bone-marrow transplantation for chronic myelogenous leukaemiaB Speck, M M Bortin, R Champlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1983
Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancerH M Lazarus, R H Herzig, J Graham-Pole, et al.
Blood|October 1, 1993
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phaseJ M Goldman, R Szydlo, M M Horowitz, et al.
Annals of Internal Medicine|June 15, 1993
High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant GroupS N Wolff, J W Fay, R H Herzig, et al.
Pageof 10